
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
INC Research Holdings, Inc. announced the launch of its Psychiatry Catalyst Site Network as part of its Catalyst program, which was introduced in 2016. The Psychiatry Catalyst Site Network was created to respond to the growth and pipeline of psychiatric studies and support oncology and vaccine clinical research.
Read the full release






